Search

everythinglearnresearchcommunity

for

Search:↓

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

DHT, a testosterone byproduct, causes male pattern baldness.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Prolactin slows down hair growth in mice.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormonal therapies are safe and effective for treating adult women's acne.

Minoxidil is mostly safe, but high doses can cause electrolyte imbalances and heart issues in dogs.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Minoxidil helps some bald men, but most lose hair again when stopping.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Reproductive factors can increase hypertension risk and affect cardiovascular health.